尋找研究成果

在所有內容中搜尋

為 研究成果 進行篩選

搜尋概念
已選取的篩選器

出版年份

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2011

作者

  • Wu-Chou Su
2014

Verification of wild-type EGFR status in non-small cell lung carcinomas using a mutant-enriched PCR on selected cases

Chen, Y. L., Lu, C. C., Yang, S. C., Su, W. P., Lin, Y. L., Chen, W. L., Huang, W., Su, W. C., Chow, N. H. & Ho, C. L., 2014 九月, 於 : Journal of Molecular Diagnostics. 16, 5, p. 486-494 9 p.

研究成果: Article

7 引文 斯高帕斯(Scopus)
2019
開啟存取
1 引文 斯高帕斯(Scopus)
2011

Malignant pleural effusion cells show aberrant glucose metabolism gene expression

Lin, C. C., Chen, L. C., Tseng, V. S., Yan, J. J., Lai, W. W., Su, W. P., Lin, C. H., Huang, C. Y. F. & Su, W. C., 2011 六月 1, 於 : European Respiratory Journal. 37, 6, p. 1453-1465 13 p.

研究成果: Article

17 引文 斯高帕斯(Scopus)
2013
7 引文 斯高帕斯(Scopus)
2011

Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: A multicenter phase II study

Chang, P. M. H., Tzeng, C. H., Chen, M. H., Tsao, C. J., Su, W. C., Hwang, W. S., Chang, Y. F., Chang, S. Y. & Yang, M. H., 2011 十二月 1, 於 : Cancer Chemotherapy and Pharmacology. 68, 6, p. 1477-1484 8 p.

研究成果: Article

13 引文 斯高帕斯(Scopus)
2015
8 引文 斯高帕斯(Scopus)
2013
62 引文 斯高帕斯(Scopus)
2016

Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer

Scagliotti, G., Kang, J. H., Smith, D., Rosenberg, R., Park, K., Kim, S. W., Su, W. C., Boyd, T. E., Richards, D. A., Novello, S., Hynes, S. M., Myrand, S. P., Lin, J., Smyth, E. N., Wijayawardana, S., Lin, A. B. & Pinder-Schenck, M., 2016 十月 1, 於 : Investigational New Drugs. 34, 5, p. 625-635 11 p.

研究成果: Article

26 引文 斯高帕斯(Scopus)
2013

An open-label safety study of first-line bevacizumab in combination with standard chemotherapy in Chinese patients with metastatic colorectal cancer treated in an expanded access program in Taiwan

Lee, K. D., Chen, H. H., Wang, H. M., Tsao, C. J., Hsu, T. C., Chiu, C. F., Su, W. C. & Wang, J. Y., 2013 五月 1, 於 : Oncology (Switzerland). 84, 5, p. 299-304 6 p.

研究成果: Article

2 引文 斯高帕斯(Scopus)
2019

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation

Yang, J. C. H., Gadgeel, S. M., Sequist, L. V. D., Wu, C. L., Papadimitrakopoulou, V. A., Su, W. C., Fiore, J., Saraf, S., Raftopoulos, H. & Patnaik, A., 2019 三月, 於 : Journal of Thoracic Oncology. 14, 3, p. 553-559 7 p.

研究成果: Article

12 引文 斯高帕斯(Scopus)
2015

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): Analysis of overall survival data from two randomised, phase 3 trials

Yang, J. C. H., Wu, Y. L., Schuler, M., Sebastian, M., Popat, S., Yamamoto, N., Zhou, C., Hu, C. P., O'Byrne, K., Feng, J., Lu, S., Huang, Y., Geater, S. L., Lee, K. Y., Tsai, C. M., Gorbunova, V., Hirsh, V., Bennouna, J., Orlov, S., Mok, T. 及其他8, Boyer, M., Su, W. C., Lee, K. H., Kato, T., Massey, D., Shahidi, M., Zazulina, V. & Sequist, L. V., 2015 二月 1, 於 : The Lancet Oncology. 16, 2, p. 141-151 11 p.

研究成果: Article

849 引文 斯高帕斯(Scopus)
2013

EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients

Yang, S. Y., Yang, T. Y., Li, Y. J., Chen, K. C., Liao, K. M., Hsu, K. H., Tsai, C. R., Chen, C. Y., Hsu, C. P., Hsia, J. Y., Chuang, C. Y., Tsai, Y. H., Chen, K. Y., Huang, M. S., Su, W. C., Chen, Y. M., Hsiung, C. A., Shen, C. Y., Chang, G. C., Yang, P. C. 及其他1, Chen, C. J., 2013 一月 15, 於 : International Journal of Cancer. 132, 2, p. 449-458 10 p.

研究成果: Article

10 引文 斯高帕斯(Scopus)
2020

Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan

Chen, Y. M., Chih-Hsin Yang, J., Su, W. C., Chong, I. W., Hsia, T. C., Lin, M. C., Chang, G. C., Chiu, C. H., Ho, C. C., Wu, S. Y., Hung, J. Y., Wang, C. C., Yang, T. Y. & Yu, C. J., 2020 一月 1, (Accepted/In press) 於 : Journal of the Formosan Medical Association.

研究成果: Article

開啟存取
2014

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

Chao, Y., Hsieh, J. S., Yeh, H. T., Su, Y. C., Wu, C. C., Chen, J. S., Tai, C. J., Bai, L. Y., Yeh, K. H., Su, W. C. & Li, C. P., 2014 四月, 於 : Cancer Chemotherapy and Pharmacology. 73, 4, p. 799-806 8 p.

研究成果: Article

9 引文 斯高帕斯(Scopus)
2019
18 引文 斯高帕斯(Scopus)
2013
15 引文 斯高帕斯(Scopus)
2018

Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer

Gerber, D. E., Horn, L., Boyer, M., Sanborn, R., Natale, R., Palmero, R., Bidoli, P., Bondarenko, I., Germonpre, P., Ghizdavescu, D., Kotsakis, A., Lena, H., Losonczy, G., Park, K., Su, W. C., Tang, M., Lai, J., Kallinteris, N. L., Shan, J. S., Reck, M. 及其他1, Spigel, D. R., 2018 七月 1, 於 : Annals of Oncology. 29, 7, p. 1548-1553 6 p.

研究成果: Article

7 引文 斯高帕斯(Scopus)

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

John, T., Akamatsu, H., Delmonte, A., Su, W. C., Lee, J. S., Chang, G. C., Huang, X., Jenkins, S. & Wu, Y. L., 2018 十二月, 於 : Lung Cancer. 126, p. 133-138 6 p.

研究成果: Article

6 引文 斯高帕斯(Scopus)
2011

EGFR L858R mutation and polymorphisms of genes related to estrogen biosynthesis and metabolism in never-smoking female lung adenocarcinoma patients

Yang, S. Y., Yang, T. Y., Chen, K. C., Li, Y. J., Hsu, K. H., Tsai, C. R., Chen, C. Y., Hsu, C. P., Hsia, J. Y., Chuang, C. Y., Tsai, Y. H., Chen, K. Y., Huang, M. S., Su, W. C., Chen, Y. M., Hsiung, C. A., Shen, C. Y., Chang, G. C., Yang, P. C. & Chen, C. J., 2011 四月 15, 於 : Clinical Cancer Research. 17, 8, p. 2149-2158 10 p.

研究成果: Article

22 引文 斯高帕斯(Scopus)

Epidermal growth factor receptor mutation status in stage i lung adenocarcinoma with different image patterns

Hsu, K. H., Chen, K. C., Yang, T. Y., Yeh, Y. C., Chou, T. Y., Chen, H. Y., Tsai, C. R., Chen, C. Y., Hsu, C. P., Hsia, J. Y., Chuang, C. Y., Tsai, Y. H., Chen, K. Y., Huang, M. S., Su, W. C., Chen, Y. M., Hsiung, C. A., Chang, G. C., Chen, C. J. & Yang, P. C., 2011 六月, 於 : Journal of Thoracic Oncology. 6, 6, p. 1066-1072 7 p.

研究成果: Article

34 引文 斯高帕斯(Scopus)
2014

Sp1-mediated microRNA-182 expression regulates lung cancer progression

Yang, W. B., Chen, P. H., Hsu, T. I., Fu, T. F., Su, W. C., Liaw, H., Chang, W. C. & Hung, J. J., 2014, 於 : Oncotarget. 5, 3, p. 740-753 14 p.

研究成果: Article

50 引文 斯高帕斯(Scopus)
2015

R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability

Chen, H. Y., Yu, S. L., Ho, B. C., Su, K. Y., Hsu, Y. C., Chang, C. S., Li, Y. C., Yang, S. Y., Hsu, P. Y., Ho, H., Chang, Y. H., Chen, C. Y., Yang, H. I., Hsu, C. P., Yang, T. Y., Chen, K. C., Hsu, K. H., Tseng, J. S., Hsia, J. Y., Chuang, C. Y. 及其他18, Yuan, S., Lee, M. H., Liu, C. H., Wu, G. I., Hsiung, C. A., Chen, Y. M., Wang, C. L., Huang, M. S., Yu, C. J., Chen, K. Y., Tsai, Y. H., Su, W. C., Chen, H. W., Chen, J. J. W., Chen, C. J., Chang, G. C., Yang, P. C. & Li, K. C., 2015 七月 10, 於 : Journal of Clinical Oncology. 33, 20, p. 2303-2310 8 p.

研究成果: Article

44 引文 斯高帕斯(Scopus)
2016
78 引文 斯高帕斯(Scopus)

Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: Results of an international randomized phase II trial (JASINT1)

De Santis, M., Wiechno, P. J., Bellmunt, J., Lucas, C., Su, W. C., Albiges, L., Lin, C. C., Senkus-Konefka, E., Flechon, A., Mourey, L., Necchi, A., Loidl, W. C., Retz, M. M., Vaissière, N. & Culine, S., 2016 三月 1, 於 : Annals of Oncology. 27, 3, p. 449-454 6 p., mdv609.

研究成果: Article

30 引文 斯高帕斯(Scopus)
2013

Risk factors for primary lung cancer among never smokers by gender in a matched case-control study

Lo, Y. L., Hsiao, C. F., Chang, G. C., Tsai, Y. H., Huang, M. S., Su, W. C., Chen, Y. M., Hsin, C. W., Chang, C. H., Yang, P. C., Chen, C. J. & Hsiung, C. A., 2013 三月 1, 於 : Cancer Causes and Control. 24, 3, p. 567-576 10 p.

研究成果: Article

32 引文 斯高帕斯(Scopus)
2018
開啟存取
1 引文 斯高帕斯(Scopus)
4 引文 斯高帕斯(Scopus)
2017
3 引文 斯高帕斯(Scopus)
2014

Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer

Shen, Y. C., Li, C. P., Yen, C-J., Hsu, C., Lin, Y. L., Lin, Z. Z., Chen, L. T., Su, W-C., Chao, Y., Yeh, K. H. & Cheng, A. L., 2014 一月 1, 於 : Oncology (Switzerland). 87, 2, p. 104-113 10 p.

研究成果: Article

9 引文 斯高帕斯(Scopus)
2015

Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: A report from the female lung cancer consortium in Asia

Machiela, M. J., Hsiung, C. A., Shu, X. O., Seow, W. J., Wang, Z., Matsuo, K., Hong, Y. C., Seow, A., Wu, C., Hosgood, H. D., Chen, K., Wang, J. C., Wen, W., Cawthon, R., Chatterjee, N., Hu, W., Caporaso, N. E., Park, J. Y., Chen, C. J., Kim, Y. H. 及其他112, Kim, Y. T., Landi, M. T., Shen, H., Lawrence, C., Burdett, L., Yeager, M., Chang, I. S., Mitsudomi, T., Kim, H. N., Chang, G. C., Bassig, B. A., Tucker, M., Wei, F., Yin, Z., An, S. J., Qian, B., Lee, V. H. F., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Kim, J. H., Gao, Y. T., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Hutchinson, A., Wang, W. C., Klein, R. J., Chung, C. C., Oh, I. J., Chen, K. Y., Berndt, S. I., Wu, W., Chang, J., Zhang, X. C., Huang, M. S., Zheng, H., Wang, J., Zhao, X., Li, Y., Choi, J. E., Su, W. C., Park, K. H., Sung, S. W., Chen, Y. M., Liu, L., Kang, C. H., Hu, L., Chen, C. H., Pao, W., Kim, Y. C., Yang, T. Y., Xu, J., Guan, P., Tan, W., Su, J., Wang, C. L., Li, H., Sihoe, A. D. L., Zhao, Z., Chen, Y., Choi, Y. Y., Hung, J. Y., Kim, J. S., Yoon, H. I., Cai, Q., Lin, C. C., Park, I. K., Xu, P., Dong, J., Kim, C., He, Q., Perng, R. P., Kohno, T., Kweon, S. S., Chen, C. Y., Vermeulen, R. C. H., Wu, J., Lim, W. Y., Chen, K. C., Chow, W. H., Ji, B. T., Chan, J. K. C., Chu, M., Li, Y. J., Yokota, J., Li, J., Chen, H., Xiang, Y. B., Yu, C. J., Kunitoh, H., Wu, G., Jin, L., Lo, Y. L., Shiraishi, K., Chen, Y. H., Lin, H. C., Wu, T., Wong, M. P., Wu, Y. L., Yang, P. C., Zhou, B., Shin, M. H., Fraumeni, J. F., Zheng, W., Lin, D., Chanock, S. J., Rothman, N. & Lan, Q., 2015 七月 15, 於 : International Journal of Cancer. 137, 2, p. 311-319 9 p.

研究成果: Article

52 引文 斯高帕斯(Scopus)
2016

Epidermal growth factor receptor mutation and anaplastic lymphoma kinase gene fusion: Detection in malignant pleural effusion by RNA or PNA analysis

Chen, Y. L., Lee, C. T., Lu, C. C., Yang, S. C., Chen, W. L., Lee, Y. C., Yang, C. H., Peng, S. L., Su, W. C., Chow, N. H. & Ho, C. L., 2016 六月, 於 : PloS one. 11, 6, e0158125.

研究成果: Article

11 引文 斯高帕斯(Scopus)
2015

Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphoma

Tsai, H. J., Lin, S. F., Chen, C. C., Chen, T. Y., Su, W. C., Hwang, W. L., Lin, J. C., Chiou, T. J., Kao, W. Y., Chiu, C. F., Chang, Y. F., Chang, J. S., Chang, M. C. & Su, I. J., 2015 二月 1, 於 : European Journal of Haematology. 94, 2, p. 130-137 8 p.

研究成果: Article

17 引文 斯高帕斯(Scopus)

Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA)

Hosgood, H. D., Song, M., Hsiung, C. A., Yin, Z., Shu, X. O., Wang, Z., Chatterjee, N., Zheng, W., Caporaso, N., Burdette, L., Yeager, M., Berndt, S. I., Landi, M. T., Chen, C. J., Chang, G. C., Hsiao, C. F., Tsai, Y. H., Chien, L. H., Chen, K. Y., Huang, M. S. 及其他46, Su, W. C., Chen, Y. M., Chen, C. H., Yang, T. Y., Wang, C. L., Hung, J. Y., Lin, C. C., Perng, R. P., Chen, C. Y., Chen, K. C., Li, Y. J., Yu, C. J., Chen, Y. S., Chen, Y. H., Tsai, F. Y., Kim, C., Seow, W. J., Bassig, B. A., Wu, W., Guan, P., He, Q., Gao, Y. T., Cai, Q., Chow, W. H., Xiang, Y. B., Lin, D., Wu, C., Wu, Y. L., Shin, M. H., Hong, Y. C., Matsuo, K., Chen, K., Wong, M. P., Lu, D., Jin, L., Wang, J. C., Seow, A., Wu, T., Shen, H., Fraumeni, J. F., Yang, P. C., Chang, I. S., Zhou, B., Chanock, S. J., Rothman, N. & Lan, Q., 2015 二月 6, 於 : Human genetics. 134, 3, p. 333-341 9 p.

研究成果: Article

23 引文 斯高帕斯(Scopus)
2020

Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1‒Positive, Advanced Non‒Small-Cell Lung Cancer in the KEYNOTE-010 Study

Herbst, R. S., Garon, E. B., Kim, D. W., Cho, B. C., Perez-Gracia, J. L., Han, J. Y., Arvis, C. D., Majem, M., Forster, M. D., Monnet, I., Novello, S., Szalai, Z., Gubens, M. A., Su, W. C., Ceresoli, G. L., Samkari, A., Jensen, E. H., Lubiniecki, G. M. & Baas, P., 2020 五月 10, 於 : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 14, p. 1580-1590 11 p.

研究成果: Article

3 引文 斯高帕斯(Scopus)
2015

Estrogen receptor gene polymorphisms and lung adenocarcinoma risk in never-smoking women

Chen, K. Y., Hsiao, C. F., Chang, G. C., Tsai, Y. H., Su, W. C., Chen, Y. M., Huang, M. S., Tsai, F. Y., Jiang, S. S., Chang, I. S., Chen, C. Y., Hsiung, C. A., Chen, C. J. & Yang, P. C., 2015 十月 1, 於 : Journal of Thoracic Oncology. 10, 10, p. 1413-1420 8 p.

研究成果: Article

6 引文 斯高帕斯(Scopus)
2017
3 引文 斯高帕斯(Scopus)
2020
開啟存取
2017
23 引文 斯高帕斯(Scopus)
2015

Antibody-free isolation of rare cancer cells from blood based on 3D lateral dielectrophoresis

Cheng, I. F., Huang, W. L., Chen, T. Y., Liu, C. W., Lin, Y. D. & Su, W. C., 2015 七月 21, 於 : Lab on a Chip. 15, 14, p. 2950-2959 10 p.

研究成果: Article

43 引文 斯高帕斯(Scopus)
2017
22 引文 斯高帕斯(Scopus)
2019
開啟存取
2015
33 引文 斯高帕斯(Scopus)
2018
4 引文 斯高帕斯(Scopus)
2014

A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies

Lin, C. C., Su, W. C., Yen, C. J., Hsu, C. H., Su, W. P., Yeh, K. H., Lu, Y. S., Cheng, A. L., Huang, D. C. L., Fritsch, H., Voss, F., Taube, T. & Yang, J. C. H., 2014 五月 13, 於 : British Journal of Cancer. 110, 10, p. 2434-2440 7 p.

研究成果: Article

49 引文 斯高帕斯(Scopus)
9 引文 斯高帕斯(Scopus)

Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer

Wei, F., Lin, C. C., Joon, A., Feng, Z., Troche, G., Lira, M. E., Chia, D., Mao, M., Ho, C. L., Su, W. C. & Wong, D. T. W., 2014 十一月 15, 於 : American Journal of Respiratory and Critical Care Medicine. 190, 10, p. 1117-1126 10 p.

研究成果: Article

81 引文 斯高帕斯(Scopus)
2017

Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study

Ahn, M. J., Kim, D. W., Cho, B. C., Kim, S. W., Lee, J. S., Ahn, J. S., Kim, T. M., Lin, C. C., Kim, H. R., John, T., Kao, S., Goldman, J. W., Su, W. C., Natale, R., Rabbie, S., Harrop, B., Overend, P., Yang, Z. & Yang, J. C. H., 2017 十一月, 於 : The Lancet Respiratory Medicine. 5, 11, p. 891-902 12 p.

研究成果: Article

34 引文 斯高帕斯(Scopus)
2016
7 引文 斯高帕斯(Scopus)
2020

Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts

Bang, Y. J., Su, W. C., Schuler, M., Nam, D. H., Lim, W. T., Bauer, T. M., Azaro, A., Poon, R. T. P., Hong, D., Lin, C. C., Akimov, M., Ghebremariam, S., Zhao, S., Giovannini, M. & Ma, B., 2020 二月 1, 於 : Cancer Science. 111, 2, p. 536-547 12 p.

研究成果: Article

開啟存取
3 引文 斯高帕斯(Scopus)